DRIVIXTI Trademark

Trademark Overview

On Monday, May 7, 2018, a trademark application was filed for DRIVIXTI with the United States Patent and Trademark Office. The USPTO has given the DRIVIXTI trademark a serial number of 87910246. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 23, 2022. This trademark is owned by Bristol-Myers Squibb Company. The DRIVIXTI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer
drivixti

General Information

Serial Number87910246
Word MarkDRIVIXTI
Filing DateMonday, May 7, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 23, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 19, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 16, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10016
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events

Event DateEvent Description
Monday, May 23, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 23, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, October 21, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 20, 2021SOU EXTENSION 5 GRANTED
Monday, October 18, 2021SOU EXTENSION 5 FILED
Monday, October 18, 2021TEAS EXTENSION RECEIVED
Thursday, April 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 30, 2021SOU EXTENSION 4 GRANTED
Tuesday, March 30, 2021SOU EXTENSION 4 FILED
Tuesday, March 30, 2021TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 3 GRANTED
Friday, October 16, 2020SOU EXTENSION 3 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 11, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, November 10, 2020EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 10, 2020PETITION TO REVIVE-GRANTED
Tuesday, November 10, 2020TEAS PETITION TO REVIVE RECEIVED
Saturday, April 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 16, 2020SOU EXTENSION 2 GRANTED
Thursday, April 16, 2020SOU EXTENSION 2 FILED
Thursday, April 16, 2020TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019SOU EXTENSION 1 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 1 FILED
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Tuesday, April 16, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 19, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 19, 2019PUBLISHED FOR OPPOSITION
Wednesday, January 30, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 19, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 19, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 18, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 18, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 18, 2018NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 18, 2018PRIORITY ACTION E-MAILED
Monday, June 18, 2018PRIORITY ACTION WRITTEN
Friday, June 15, 2018ASSIGNED TO EXAMINER
Wednesday, May 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 10, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

drivixti diseases pharmaceutical disorders cancer anti human preparations treatment transplant rejection